IWWM-12: Highlights from young investigator research

During the 12th International Workshop on Waldenstrom's Macroglobulinemia (IWWM-12), the Lymphoma Hub was pleased to speak to Anne Marie Becking and Wouter Verhaar, Amsterdam UMC, Amsterdam, NL. We asked them about their highlights from the workshop and their areas of clinical interest in Waldenstrom’s macroglobulinemia (WM).

In this interview, recorded at IWWM-12, Anne-Marie Becking and Wouter Verhaar, both medical doctors undertaking PhDs, discuss their research and clinical interests in WM. Verhaar focuses on the complexity of WM, particularly the role of IgM, its structural variations, and complications such as amyloidosis, aiming to explore new treatment options. He also highlights the collaborative spirit of the conference as a key benefit for young researchers. Becking specializes in glutenin disease, studying clonal characterization in the bone marrow, and conducts qualitative research through the WM-VOICE study, which evaluates patient preferences for treatment. Becking closes by emphasizing the value of the conference in showcasing global efforts toward WM therapies, highlighting the importance of translating research into patient-centered care.

This educational resource was independently supported by BeiGene. All content was developed by SES in collaboration with an expert steering committee; funders are allowed no influence on the content of this resource.